has been suggested as a diagnostic modality in HCC. The purpose of this study is to evaluate the accuracy of FDG-PET for staging of HCC after surgical resection and histological confirmation. Methods: We retrospectively collected data of 56 patients that underwent FDG-PET before surgical resection for HCC March 2011-May 2017, all of whom were suitable for resection by conventional HCC staging. Results of the maximal standardized uptake value (SUVmax) were compared with histological confirmation. Results: A larger tumor size was related with higher SUVmax (≥4.9). The serum alpha-feto protein was associated with SUVmax. Recurrence rate was higher in patients with higher SUVmax and patients with lower SUVmax had a better survival rate. Conclusions: The SUVmax correlates well with tumor size and factors associated with biological behavior of HCC such as alpha-feto protein, and it could be a beneficial modality in providing prognostic information for HCC. 
INTRODUCTION
Hepatocellular carcinoma (HCC) is one of the most common malignancies and has been ranked 7th and 5th for cancer incidence worldwide and in South Korea, respectively. HCC is the 3rd leading cause of cancer-related deaths. 1 Prognosis of patients with HCC is usually poor, and predicting life expectancy is difficult because of variable factors such as portal vein thrombosis, tumor stage, alpha-fetoprotein (AFP), Child-Pugh score, and high recurrence rate of the tumor. 2 Therefore, accurate staging of HCC is crucial. Accurate staging is crucial because only patients with small tumors (＜5 cm) without distant metastasis would benefit from liver resection or liver transplantation as a curative treatment. 3 Conventionally, dynamic computed tomography (CT), ultrasonography (USG), and magnetic resonance imaging (MRI) are used as imaging modalities in staging and diagnosis of HCC.
Positron emission tomography (PET) is an imaging modality using positron-emitting markers. 81.5%) and it is superior to other methods in detecting occult metastasis. 8 However, few studies report accuracy and clinical aspects of FDG-PET in HCC.
In this study, we retrospectively evaluated the correlation of FDG-PET imaging, characteristics of HCC and the role of FDG-PET in diagnosis and staging of HCC after surgical resection and histological confirmation. Survival rates according to the SUVmax Among the 56 patients, 14 patients experienced recurrent HCC. Four patients had SUVmax＜4.9 and 10 patients had SUVmax≥4.9. Disease-free survival above and below the cut-off value (SUVmax 4.9) was different. The 2-year disease-free survival was 37% for patients with SUVmax of less than 4.9 but was 42% for those with SUVmax of 4.9 or more. The result was not statistically significant (p=0.262) (Fig. 1) . Nine patients died during the follow-up period. Overall survival was 81% in the group with SUVmax of 4.9 or more and 86% for those with SUVmax of less than 4.9, that was statistically insignificant (p=0.717) (Fig. 2) .
MATERIALS AND METHODS

Subjects
Fig. 2.
Over-all survival rate in in group of standard uptake value (SUV)≥4.9 and SUV＜4.9. 
